#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14234	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2552	678.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1670	1670	C	882	C	882	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24120	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4049	743.5	0	.	n	.	0	T695C	SNP	695	695	T	1226	1226	C	870	C	869	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24120	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4049	743.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1868	1868	A	986	A,C,G	983,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24120	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4049	743.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2502	2502	C	845	C,G,A	843,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24120	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4049	743.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2576	2576	A	821	A,G	820,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24120	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4049	743.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3128	3128	C	873	C	873	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2086	folP	855	855	100.0	folP.l15.c4.ctg.1	2239	116.3	1	SNP	p	R229S	0	.	.	685	687	CGC	1375	1377	CGC	198;198;198	C;G,T;C,G	198;197,1;197,1	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4604	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3910	146.9	1	SNP	p	S91F	0	.	.	271	273	TCC	780	782	TCC	178;176;175	T;C,G;C	178;175,1;175	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4604	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3910	146.9	1	SNP	p	D95N	0	.	.	283	285	GAC	792	794	GAC	176;177;175	G,A;A,T,G;C	175,1;175,1,1;175	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4604	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3910	146.9	1	SNP	p	D95G	0	.	.	283	285	GAC	792	794	GAC	176;177;175	G,A;A,T,G;C	175,1;175,1,1;175	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	1726	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1902	113.3	1	SNP	p	G45D	1	.	.	133	135	GAC	863	865	GAC	183;184;183	G,A;A,G;C,T	182,1;182,2;182,1	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1040	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c17.ctg.1	1625	79.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4636	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3425	168.9	1	SNP	p	D86N	0	.	.	256	258	GAC	832	834	GAC	226;227;229	G;A;C,G	226;227;228,1	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4636	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3425	168.9	1	SNP	p	S88P	0	.	.	262	264	TCC	838	840	TCC	232;230;224	T;C;C	232;230;224	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3908	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3075	158.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1750	1752	GGC	229;228;226	G,A;G;C	228,1;228;226	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3604	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3025	148.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1626	1628	GCA	194;194;197	G,C;C;A	193,1;194;197	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3604	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3025	148.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1629	1631	ATC	197;195;197	A;T;C,A	197;195;196,1	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3604	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3025	148.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1641	1643	GTG	196;198;198	G;T;G,A	196;198;197,1	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3604	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3025	148.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1641	1643	GTG	196;198;198	G;T;G,A	196;198;197,1	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3604	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3025	148.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2145	2147	ACC	198;196;193	A;C;C	198;196;193	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3604	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3025	148.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2199	2201	GCG	194;192;192	G;C,T,G,A;G	194;189,1,1,1;192	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3604	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3025	148.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2199	2201	GCG	194;192;192	G;C,T,G,A;G	194;189,1,1,1;192	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3604	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3025	148.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2322	2324	GGC	189;192;193	G;G,A;C	189;191,1;193	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3604	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3025	148.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2331	2333	GGC	197;200;198	G,C;G,C;C	196,1;199,1;198	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3604	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3025	148.8	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2349	2351	CTG	213;215;217	C,G;T;G	212,1;215;217	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5064	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3630	174.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1927	1929	CCG	205;203;203	C;C;G	205;203;203	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2030	porA	1146	1146	99.83	porA.l15.c17.ctg.1	2365	107.2	0	.	p	.	0	S22G	NONSYN	64	66	AGC	618	620	GGC	131;132;133	G;G,C;C	131;130,2;133	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2030	porA	1146	1146	99.83	porA.l15.c17.ctg.1	2365	107.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	800	800	C	170	C,G	169,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2766	porB1b	1047	1047	98.57	porB1b.l15.c30.ctg.1	2193	157.4	0	.	p	.	0	T18M	NONSYN	52	54	ACG	593	595	ATG	230;231;234	A,G;T,C;G,T	229,1;230,1;233,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2766	porB1b	1047	1047	98.57	porB1b.l15.c30.ctg.1	2193	157.4	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	968	970	CAA	262;265;263	C;A,C;A,G,C	261;263,1;260,1,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2766	porB1b	1047	1047	98.57	porB1b.l15.c30.ctg.1	2193	157.4	0	.	p	.	0	E212D	NONSYN	634	636	GAA	1175	1177	GAT	230;224;224	G;A;T,A	230;224;223,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2766	porB1b	1047	1047	98.57	porB1b.l15.c30.ctg.1	2193	157.4	0	.	p	.	0	H213G	NONSYN	637	639	CAT	1178	1180	GGT	224;221;220	G;G;T	224;221;220	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2766	porB1b	1047	1047	98.57	porB1b.l15.c30.ctg.1	2193	157.4	0	.	p	.	0	V215A	NONSYN	643	645	GTT	1184	1186	GCT	214;216;215	G,A;C;T	213,1;216;215	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2766	porB1b	1047	1047	98.57	porB1b.l15.c30.ctg.1	2193	157.4	0	.	p	.	0	S220T	NONSYN	658	660	AGC	1199	1201	ACT	229;227;231	A;C;T,C	229;227;230,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2766	porB1b	1047	1047	98.57	porB1b.l15.c30.ctg.1	2193	157.4	0	.	p	.	0	R257M	NONSYN	769	771	AGG	1310	1312	ATG	234;234;233	A,G;T;G	233,1;234;233	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2766	porB1b	1047	1047	98.57	porB1b.l15.c30.ctg.1	2193	157.4	0	.	p	.	0	R258S	NONSYN	772	774	AGG	1313	1315	AGC	234;235;235	A;G;C	234;235;235	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2766	porB1b	1047	1047	98.57	porB1b.l15.c30.ctg.1	2193	157.4	0	.	p	.	0	A259G	NONSYN	775	777	GCT	1316	1318	GGT	230;227;228	G,A;G;T	229,1;227;228	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2766	porB1b	1047	1047	98.57	porB1b.l15.c30.ctg.1	2193	157.4	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1430	1432	AAC	212;211;214	A,T;A;C	211,1;211;214	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2766	porB1b	1047	1047	98.57	porB1b.l15.c30.ctg.1	2193	157.4	1	SNP	p	G120K	0	.	.	358	360	GGC	899	901	GGC	231;232;233	G;G;C,A	231;232;231,2	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9356	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5306	220.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1404	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1441	121.0	1	SNP	p	V57M	1	.	.	169	171	ATG	727	729	ATG	233;233;231	A;T;G	233;233;231	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
